Intuitive Surgical, Inc. (ISRG) Quick Ratio (Acid-Test): 3.96
Is Intuitive Surgical, Inc.’s quick ratio (acid-test) high or low?
Intuitive Surgical, Inc.'s quick ratio (acid-test) of 3.96 is in line with its 5-year average of 4.30, near the low end of its 5-year range (3.22–6.24).
The quick ratio (acid-test) for Intuitive Surgical, Inc. (ISRG) is 3.96 as of Wednesday, June 10, 2026. It is above its 12-month average by 10.31% (3.59).
ISRG Quick Ratio (Acid-Test) Chart
ISRG Average Quick Ratio (Acid-Test) Chart
ISRG Current vs Average Quick Ratio (Acid-Test) Chart
ISRG Quick Ratio (Acid-Test) Metrics
QUICK RATIO (ACID-TEST)
3.96
QUICK RATIO (ACID-TEST) AVG TTM
3.59
QUICK RATIO (ACID-TEST) AVG 3Y
3.74
QUICK RATIO (ACID-TEST) AVG 5Y
4.30
QUICK RATIO (ACID-TEST) AVG 10Y
4.78
QUICK RATIO (ACID-TEST) AVG 15Y
4.87
QUICK RATIO (ACID-TEST) AVG 20Y
4.71
CURRENT VS TTM AVG
+10.31%
CURRENT VS 3Y AVG
+5.81%
CURRENT VS 5Y AVG
-7.84%
CURRENT VS 10Y AVG
-17.22%
CURRENT VS 15Y AVG
-18.65%
CURRENT VS 20Y AVG
-15.92%
ISRG Competitors' Quick Ratio (Acid-Test)
| NAME | MARKET CAP | QUICK RATIO (ACID-TEST) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Intuitive Surgical, Inc. (ISRG) | — | 3.96 | 3.59 | 3.74 | 4.30 |
| Pfizer Inc. (PFE) | $146.36B | 0.87 | 0.90 | 0.87 | 0.95 |
| Gilead Sciences, Inc. (GILD) | $151.21B | 1.31 | 1.38 | 1.29 | 1.26 |
| Abbott Laboratories (ABT) | $154.66B | 1.18 | 1.21 | 1.20 | 1.26 |
| Danaher Corporation (DHR) | $130.25B | 1.51 | 1.28 | 1.37 | 1.36 |
| CVS Health Corporation (CVS) | $125.16B | 0.63 | 0.61 | 0.63 | 0.63 |
| Bristol-Myers Squibb Company (BMY) | $114.14B | 1.14 | 1.15 | 1.19 | 1.27 |
| Thermo Fisher Scientific Inc. (TMO) | $179.45B | 1.53 | 1.41 | 1.34 | 1.37 |
| Vertex Pharmaceuticals Incorporated (VRTX) | $110.77B | 2.46 | 2.41 | 3.31 | 3.62 |
| Amgen Inc. (AMGN) | $183.75B | 0.90 | 0.93 | 1.02 | 1.14 |
Liquidity Comparison
Quick Ratio
3.96
Excludes inventory
Current Ratio
4.87
Includes inventory
Intuitive Surgical, Inc. Quick Ratio (Acid-Test) Formula & Definition
Quick Ratio = (Current Assets − Inventory) / Current Liabilities
The quick ratio is a stricter liquidity measure that excludes inventory, showing the ability to meet short-term obligations with the most liquid assets.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
Intuitive Surgical, Inc. Quick Ratio (Acid-Test) FAQ
- What is the quick ratio (acid-test) for Intuitive Surgical, Inc. (ISRG)?
- The quick ratio (acid-test) for ISRG stock is 3.96.
- Is Intuitive Surgical, Inc.'s quick ratio (acid-test) high or low?
- Intuitive Surgical, Inc.'s quick ratio (acid-test) of 3.96 is in line with its 5-year average of 4.30, near the low end of its 5-year range (3.22–6.24).
- What is the TTM average quick ratio (acid-test) for Intuitive Surgical, Inc. (ISRG)?
- The TTM average quick ratio (acid-test) for ISRG stock is 3.59.
- What is the 3Y average quick ratio (acid-test) for Intuitive Surgical, Inc. (ISRG)?
- The 3Y average quick ratio (acid-test) for ISRG stock is 3.74.
- What is the 5Y average quick ratio (acid-test) for Intuitive Surgical, Inc. (ISRG)?
- The 5Y average quick ratio (acid-test) for ISRG stock is 4.30.
- What is the 10Y average quick ratio (acid-test) for Intuitive Surgical, Inc. (ISRG)?
- The 10Y average quick ratio (acid-test) for ISRG stock is 4.78.
- What is the 15Y average quick ratio (acid-test) for Intuitive Surgical, Inc. (ISRG)?
- The 15Y average quick ratio (acid-test) for ISRG stock is 4.87.
- What is the 20Y average quick ratio (acid-test) for Intuitive Surgical, Inc. (ISRG)?
- The 20Y average quick ratio (acid-test) for ISRG stock is 4.71.
Intuitive Surgical, Inc. Quick Ratio (Acid-Test) History
| DATE | QUICK RATIO (ACID-TEST) |
|---|---|
| 2025-12-31 | 3.96 |
| 2024-12-31 | 3.22 |
| 2023-12-31 | 4.02 |
| 2022-12-31 | 3.77 |
| 2021-12-31 | 4.57 |
| 2020-12-31 | 6.24 |
| 2019-12-31 | 3.95 |
| 2018-12-31 | 4.78 |
| 2017-12-31 | 4.31 |
| 2016-12-31 | 7.43 |
| 2015-12-31 | 6.37 |
| 2014-12-31 | 4.85 |
| 2013-12-31 | 4.60 |
| 2012-12-31 | 4.41 |
| 2011-12-31 | 5.92 |
| 2010-12-31 | 5.49 |
| 2009-12-31 | 5.06 |
| 2008-12-31 | 3.89 |
| 2007-12-31 | 4.38 |
| 2006-12-31 | 4.34 |
| 2005-12-31 | 3.34 |
| 2004-12-31 | 4.45 |
| 2003-12-31 | 4.19 |
| 2002-12-31 | 2.68 |
| 2001-12-31 | 3.90 |
| 2000-12-31 | 4.92 |
| 1999-12-31 | 2.97 |
Related Metrics
About Intuitive Surgical, Inc.
Intuitive Surgical, Inc. is a leading medical technology firm dedicated to advancing patient care by developing, producing, and commercializing sophisticated tools. These innovations empower medical professionals to deliver superior, accessible, and less-invasive treatment options to patients both within the United States and across international markets. Its flagship offering, the da Vinci Surgical System, facilitates intricate operations through a minimally disruptive approach. Expanding beyond surgical applications, the company also provides the Ion endoluminal system, designed for diagnostic interventions like minimally invasive lung biopsies. Complementing its primary systems, Intuitive Surgical supplies a comprehensive array of instruments, including stapling tools, energy devices, and essential core components. Furthermore, it offers structured training programs to ensure proficient use of its technology, alongside extensive customer support services encompassing installation, repairs, and ongoing maintenance. The firm also integrates digital capabilities to deliver unified, connected solutions that optimize hospital performance through actionable insights. Established in 1995, Intuitive Surgical maintains its corporate headquarters in Sunnyvale, California.
- Sector
- Healthcare
- Industry
- Medical - Devices
- CEO
- David J. Rosa